Prosecution Insights
Last updated: May 29, 2026

Abbott Laboratories

14 pending office actions • 10 art units • 12 examiners • 0 of 14 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days

Portfolio Summary

14
Total Pending OAs
9
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
1
Due this week
4
Due this month
0
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 7 days (1)Due ≤ 30 days (4)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
9
Medium (64%)
1
Easy (7%)
4
Unknown (29%)

Rejection Statute Mix

BucketCases
§103 only8 (57%)
§102 only1 (7%)
§112 only1 (7%)
No statute on record4 (29%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

12
Life Sciences
86% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
14% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

140 h
Manual time on pending OAs
28 h
Time saved (low, 20%)
49 h
Time saved (mid, 35%)
1.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
EVANS, CHRISTOPHER RYAN 2 58.8% +70.0%
CHERNYSHEV, OLGA N 2 54.5% +34.2%
POND, ROBERT M 1 71.0% +42.4%
SZUMNY, JONATHON A 1 58.1% +58.9%
COUNTS, GARY W 1 58.9% +29.3%
ZOU, NIANXIANG 1 64.3% +24.2%
COHEN, MICHAEL P 1 58.5% +27.6%
FRITCHMAN, REBECCA M 1 45.7% +36.1%
HERON, VELVET ELIZABETH 1 40.0% +75.0%
PAK, JOHN D 1 51.9% +37.7%

Interview Candidates (12)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18514454 DUAL ANTIPLATELET THERAPY AND TIME BASED RISK PREDICTION SZUMNY, JONATHON A 141d overdue
18306072 DEVICES AND METHODS FOR SAMPLE ANALYSIS EVANS, CHRISTOPHER RYAN 111d overdue
18905810 SYSTEM AND METHOD FOR AUTOMATED LABORATORY INVENTORY MANAGEMENT USING RFID TECHNOLOGY POND, ROBERT M 35d overdue
17747397 METHODS OF EVALUATING BRAIN INJURY IN A PEDIATRIC SUBJECT CHERNYSHEV, OLGA N 30d overdue
18253073 METHODS OF INCREASING HEIGHT AND PROMOTING LINEAR BONE GROWTH COHEN, MICHAEL P 24d overdue
18474826 BIOMARKERS AND METHODS FOR DIFFERENTIATING BETWEEN MILD AND SUPERMILD TRAUMATIC BRAIN INJURY COUNTS, GARY W 5d
17773072 BOVINE MILK-ISOLATED POWDERED EXOSOMES, NUTRITIONAL COMPOSITIONS AND METHODS PAK, JOHN D 14d
18147094 USE OF BIOMARKERS TO DETERMINE SUB-ACUTE TRAUMATIC BRAIN INJURY (TBI) IN A SUBJECT HAVING RECEIVED A HEAD COMPUTERIZED TOMOGRAPHY (CT) SCAN THAT IS NEGATIVE FOR A TBI OR NO HEAD CT SCAN FRITCHMAN, REBECCA M 27d

Top Art Units

Art UnitApps
1677 3
1671 2
1675 2
3688 1
3686 1
1678 1
1612 1
1758 1
1798 1
1699 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18905810 SYSTEM AND METHOD FOR AUTOMATED LABORATORY INVENTORY MANAGEMENT USING RFID TECHNOLOGY POND, ROBERT M 3688 §103 Non-Final OA 35d overdue Pending Oct 03, 2024
18514454 DUAL ANTIPLATELET THERAPY AND TIME BASED RISK PREDICTION SZUMNY, JONATHON A 3686 §103 Final Rejection 141d overdue Pending Nov 20, 2023
18474826 BIOMARKERS AND METHODS FOR DIFFERENTIATING BETWEEN MILD AND SUPERMILD TRAUMATIC BRAIN INJURY COUNTS, GARY W 1678 §103 Non-Final OA 5d Pending Sep 26, 2023
18344952 METHODS FOR DETERMINING SARS-COV-2 ANTIGEN AND ANTI-SARS-COV-2 ANTIBODY IN A SAMPLE ZOU, NIANXIANG 1671 §103 Final Rejection 70d Pending Jun 30, 2023
18253073 METHODS OF INCREASING HEIGHT AND PROMOTING LINEAR BONE GROWTH COHEN, MICHAEL P 1612 §103 Non-Final OA 24d overdue Pending May 16, 2023
18306072 DEVICES AND METHODS FOR SAMPLE ANALYSIS EVANS, CHRISTOPHER RYAN 1677 Other Non-Final OA 111d overdue Pending Apr 24, 2023
18147094 USE OF BIOMARKERS TO DETERMINE SUB-ACUTE TRAUMATIC BRAIN INJURY (TBI) IN A SUBJECT HAVING RECEIVED A HEAD COMPUTERIZED TOMOGRAPHY (CT) SCAN THAT IS NEGATIVE FOR A TBI OR NO HEAD CT SCAN FRITCHMAN, REBECCA M 1758 §102 Non-Final OA 27d Pending Dec 28, 2022
18147360 METHODS OF DIAGNOSING BRAIN INJURY CHERNYSHEV, OLGA N 1675 Other Non-Final OA 30d Pending Dec 28, 2022
17997506 SYSTEMS AND METHODS FOR SAMPLE ANALYSIS HERON, VELVET ELIZABETH 1798 §103 Final Rejection 63d Pending Oct 28, 2022
18045845 METHODS AND KITS FOR DETECTING OR DETERMINING AN AMOUNT OF AN ANTI-B-CORONAVIRUS ANTIBODY IN A SAMPLE EVANS, CHRISTOPHER RYAN 1677 Other Non-Final OA Pending Oct 12, 2022
17747397 METHODS OF EVALUATING BRAIN INJURY IN A PEDIATRIC SUBJECT CHERNYSHEV, OLGA N 1675 Other Final Rejection 30d overdue Pending May 18, 2022
17773072 BOVINE MILK-ISOLATED POWDERED EXOSOMES, NUTRITIONAL COMPOSITIONS AND METHODS PAK, JOHN D 1699 §103 Non-Final OA 14d Pending Apr 29, 2022
17393824 METHODS AND KITS FOR DETECTING SARS-COV-2 PROTEIN IN A SAMPLE SIFFORD, JEFFREY MARK 1671 §112 Final Rejection Pending Aug 04, 2021
16864672 DEVICES AND METHODS FOR SAMPLE ANALYSIS VOLKOV, ALEXANDER ALEXANDROVIC 1677 §103 Non-Final OA 12d Pending May 01, 2020

Managing Abbott Laboratories's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month